SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-065909
Filing Date
2023-08-11
Accepted
2023-08-11 08:58:16
Documents
65
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_longeveron.htm   iXBRL 10-Q 771303
2 CERTIFICATION f10q0623ex31-1_longeveron.htm EX-31.1 9305
3 CERTIFICATION f10q0623ex31-2_longeveron.htm EX-31.2 9418
4 CERTIFICATION f10q0623ex32-1_longeveron.htm EX-32.1 5357
10 GRAPHIC image_001.jpg GRAPHIC 49481
  Complete submission text file 0001213900-23-065909.txt   4973721

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20230630.xsd EX-101.SCH 50034
6 XBRL CALCULATION FILE lgvn-20230630_cal.xml EX-101.CAL 29202
7 XBRL DEFINITION FILE lgvn-20230630_def.xml EX-101.DEF 254902
8 XBRL LABEL FILE lgvn-20230630_lab.xml EX-101.LAB 489696
9 XBRL PRESENTATION FILE lgvn-20230630_pre.xml EX-101.PRE 265670
59 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_longeveron_htm.xml XML 507589
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 231161731
SIC: 2834 Pharmaceutical Preparations